It’s a good day to be an The Chemours Company (CC) shareholder

In the latest session, The Chemours Company (NYSE: CC) closed at 28.14 down -8.43% from its previous closing price of $30.73. In other words, the price has decreased by $-2.59 from its previous closing price. On the day, 3375025 shares were traded. CC reached its highest trading level at $29.98 during the session, while it also had its lowest trading level at $28.10.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .



For a deeper understanding of The Chemours Company’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.79. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 3.03 whereas as Long-Term Debt/Eq ratio is at 3.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on June 14, 2022, Downgraded its rating to Neutral and sets its target price to $44 from $48 previously.

Goldman Upgraded its Neutral to Buy on June 09, 2021, whereas the target price for the stock was revised from $35 to $47.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 07 when Sparks Edwin C sold 22,142 shares for $43.59 per share. The transaction valued at 965,170 led to the insider holds 101,038 shares of the business.

Ralhan Sameer sold 20,175 shares of CC for $807,202 on May 09. The SVP, CFO now owns 313,506 shares after completing the transaction at $40.01 per share. On May 06, another insider, Ralhan Sameer, who serves as the SVP, CFO of the company, sold 35,188 shares for $40.14 each. As a result, the insider received 1,412,446 and left with 313,506 shares of the company.

Valuation Measures:

As of this moment, The’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.26, and their Forward P/E ratio for the next fiscal year is 4.61. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68 while its Price-to-Book (P/B) ratio in mrq is 3.62.

Stock Price History:

Over the past 52 weeks, CC has reached a high of $44.95, while it has fallen to a 52-week low of $22.56. The 50-Day Moving Average of the stock is 34.49, while the 200-Day Moving Average is calculated to be 33.86.

Shares Statistics:

For the past three months, CC has traded an average of 1.31M shares per day and 1.42M over the past ten days. A total of 156.22M shares are outstanding, with a floating share count of 153.54M. Insiders hold about 0.70% of the company’s shares, while institutions hold 75.00% stake in the company. Shares short for CC as of Jul 14, 2022 were 4.83M with a Short Ratio of 2.91, compared to 5.11M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.11% and a Short% of Float of 3.51%.

Dividends & Splits

According to the company, the forward annual dividend rate for CC is 1.00, from 1.00 in the trailing year. Against a Trailing Annual Dividend Yield of 3.25%, it implies a Forward Annual Dividend Yield of 2.81%. The stock’s 5-year Average Dividend Yield is 3.49.

Earnings Estimates

There are 9 different market analysts currently analyzing its stock. On average, analysts expect EPS of $1.32 for the current quarter, with a high estimate of $1.44 and a low estimate of $1.16, while EPS last year was $1.27. The consensus estimate for the next quarter is $1.09, with high estimates of $1.21 and low estimates of $0.88.

Analysts are recommending an EPS of between $5.5 and $5 for the fiscal current year, implying an average EPS of $5.27. EPS for the following year is $5.91, with 11 analysts recommending between $6.82 and $5.3.

Revenue Estimates

A total of 5 analysts believe the company’s revenue will be $1.8B this quarter.It ranges from a high estimate of $1.83B to a low estimate of $1.77B. As of the current estimate, The Chemours Company’s year-ago sales were $1.58B, an estimated increase of 13.80% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $1.69B, an increase of 7.40% less than the figure of $13.80% in the same quarter last year. There is a high estimate of $1.76B for the next quarter, whereas the lowest estimate is $1.61B.

A total of 10 analysts have provided revenue estimates for CC’s current fiscal year. The highest revenue estimate was $7.26B, while the lowest revenue estimate was $6.6B, resulting in an average revenue estimate of $7.03B. In the same quarter a year ago, actual revenue was $6.34B, up 10.80% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $7.39B in the next fiscal year. The high estimate is $7.68B and the low estimate is $7B. The average revenue growth estimate for next year is up 5.20% from the average revenue estimate for this year.